RM
INSIDER · UTHR · UNITED THERAPEUTICS Corp · CHAIRPERSON & CEO
ROTHBLATT MARTINE A
Every open-market transaction filed under this name, Sep 18 to Oct 19.
Filings
300
0 buys · 300 sells
Bought
—
open market, at cost
Sold
$104.7M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $556.88 | $45K | +1.2% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $554.00 | $66K | +1.7% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $552.78 | $22K | +1.9% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $551.77 | $44K | +2.1% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $549.66 | $66K | +2.5% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 360 | $549.01 | $198K | +2.6% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 559 | $547.98 | $306K | +2.8% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 416 | $547.00 | $228K | +3.0% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,065 | $545.90 | $581K | +3.2% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,040 | $544.89 | $567K | +3.4% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,240 | $543.73 | $674K | +3.6% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 260 | $542.81 | $141K | +3.8% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 520 | $541.38 | $282K | +4.1% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,800 | $540.63 | $973K | +4.2% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 880 | $539.79 | $475K | +4.4% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $538.54 | $86K | +4.6% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $537.11 | $129K | +4.9% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 360 | $536.36 | $193K | +5.1% |
| Oct 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $534.75 | $86K | +5.4% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $543.85 | $22K | +3.6% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 391 | $542.67 | $212K | +3.8% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 169 | $541.62 | $92K | +4.0% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 239 | $539.60 | $129K | +4.4% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 401 | $538.55 | $216K | +4.6% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 760 | $537.74 | $409K | +4.8% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 865 | $536.66 | $464K | +5.0% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 535 | $535.67 | $287K | +5.2% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 640 | $534.41 | $342K | +5.4% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,818 | $533.32 | $970K | +5.7% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,378 | $532.46 | $1.3M | +5.8% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,024 | $531.54 | $544K | +6.0% |
| Oct 16 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $530.48 | $127K | +6.2% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $551.50 | $66K | +2.2% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $550.72 | $110K | +2.3% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,009 | $549.76 | $555K | +2.5% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,039 | $548.89 | $1.1M | +2.7% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,166 | $547.83 | $1.2M | +2.9% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 601 | $546.94 | $329K | +3.0% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 825 | $545.87 | $450K | +3.2% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 269 | $544.75 | $147K | +3.4% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 371 | $543.39 | $202K | +3.7% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 456 | $542.68 | $247K | +3.8% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,163 | $541.59 | $630K | +4.0% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 281 | $540.48 | $152K | +4.3% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $546.00 | $22K | +3.2% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 480 | $545.48 | $262K | +3.3% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 480 | $544.35 | $261K | +3.5% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $543.15 | $217K | +3.7% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 883 | $542.07 | $479K | +4.0% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,930 | $541.20 | $1M | +4.1% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,002 | $540.23 | $1.1M | +4.3% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 525 | $539.09 | $283K | +4.5% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,127 | $538.00 | $606K | +4.7% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 633 | $537.19 | $340K | +4.9% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $535.89 | $214K | +5.2% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $534.63 | $128K | +5.4% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $532.48 | $21K | +5.8% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $531.19 | $64K | +6.1% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $530.09 | $85K | +6.3% |
| Oct 14 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $526.07 | $21K | +7.1% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $551.49 | $44K | +2.2% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $550.59 | $88K | +2.3% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 502 | $549.47 | $276K | +2.6% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 698 | $548.49 | $383K | +2.7% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 630 | $547.47 | $345K | +2.9% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,452 | $546.46 | $793K | +3.1% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,507 | $545.52 | $822K | +3.3% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,492 | $544.56 | $812K | +3.5% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,340 | $543.48 | $1.3M | +3.7% |
| Oct 13 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 639 | $542.76 | $347K | +3.8% |
| Oct 12 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 135 | $554.46 | $75K | +1.6% |
| Oct 12 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 558 | $552.93 | $309K | +1.9% |
| Oct 12 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,857 | $551.92 | $1M | +2.1% |
| Oct 12 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,628 | $551.10 | $1.4M | +2.2% |
| Oct 12 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,565 | $550.03 | $1.4M | +2.4% |
| Oct 12 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,329 | $549.01 | $730K | +2.6% |
| Oct 12 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 428 | $548.13 | $235K | +2.8% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 423 | $550.72 | $233K | +2.3% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,478 | $549.93 | $813K | +2.5% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,641 | $548.93 | $1.4M | +2.7% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 878 | $548.01 | $481K | +2.8% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $546.60 | $131K | +3.1% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $545.90 | $218K | +3.2% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $544.54 | $218K | +3.5% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $543.21 | $130K | +3.7% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $541.51 | $22K | +4.1% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 320 | $540.74 | $173K | +4.2% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $539.23 | $108K | +4.5% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $538.33 | $215K | +4.7% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 360 | $537.05 | $193K | +4.9% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $536.09 | $214K | +5.1% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 640 | $534.80 | $342K | +5.4% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 320 | $533.80 | $171K | +5.6% |
| Oct 9 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $531.92 | $64K | +5.9% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $541.23 | $22K | +4.1% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 424 | $540.51 | $229K | +4.3% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,091 | $539.58 | $589K | +4.4% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 605 | $538.60 | $326K | +4.6% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,016 | $537.53 | $546K | +4.8% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 824 | $536.61 | $442K | +5.0% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 480 | $535.46 | $257K | +5.2% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 920 | $534.28 | $492K | +5.5% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 800 | $533.36 | $427K | +5.6% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 600 | $532.07 | $319K | +5.9% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,061 | $531.07 | $563K | +6.1% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 199 | $530.13 | $105K | +6.3% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $528.63 | $106K | +6.6% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 273 | $527.57 | $144K | +6.8% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 767 | $526.66 | $404K | +7.0% |
| Oct 8 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $525.50 | $105K | +7.2% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $556.48 | $223K | +1.3% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 930 | $555.77 | $517K | +1.4% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 485 | $554.51 | $269K | +1.6% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 185 | $553.70 | $102K | +1.8% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 440 | $552.29 | $243K | +2.0% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 486 | $551.09 | $268K | +2.2% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 874 | $550.14 | $481K | +2.4% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,173 | $549.13 | $644K | +2.6% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 387 | $548.18 | $212K | +2.8% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 629 | $546.94 | $344K | +3.0% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 493 | $545.85 | $269K | +3.2% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,098 | $544.82 | $1.1M | +3.4% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 744 | $543.76 | $405K | +3.6% |
| Oct 7 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 176 | $542.73 | $96K | +3.8% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $545.50 | $44K | +3.3% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 842 | $544.75 | $459K | +3.4% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 558 | $543.99 | $304K | +3.6% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $542.49 | $65K | +3.9% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 380 | $541.55 | $206K | +4.1% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,054 | $540.68 | $1.1M | +4.2% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,606 | $539.68 | $867K | +4.4% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,088 | $538.61 | $586K | +4.6% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 133 | $537.58 | $71K | +4.8% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 323 | $536.25 | $173K | +5.1% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 734 | $535.71 | $393K | +5.2% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 167 | $534.30 | $89K | +5.5% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 215 | $533.14 | $115K | +5.7% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 320 | $531.94 | $170K | +5.9% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $530.13 | $127K | +6.3% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 360 | $528.72 | $190K | +6.6% |
| Oct 6 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 280 | $527.90 | $148K | +6.7% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 360 | $546.63 | $197K | +3.1% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 920 | $545.69 | $502K | +3.3% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,260 | $544.59 | $686K | +3.5% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 783 | $543.54 | $426K | +3.7% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 918 | $542.56 | $498K | +3.9% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,239 | $541.66 | $671K | +4.0% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,028 | $540.50 | $556K | +4.3% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 931 | $539.50 | $502K | +4.4% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 655 | $538.62 | $353K | +4.6% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 905 | $537.43 | $486K | +4.8% |
| Oct 5 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 501 | $536.26 | $269K | +5.1% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $574.23 | $23K | −1.9% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $572.44 | $46K | −1.6% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $570.70 | $68K | −1.3% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $569.90 | $137K | −1.1% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $566.58 | $45K | −0.5% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $563.88 | $45K | −0.1% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $562.35 | $22K | +0.2% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $560.66 | $67K | +0.5% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $558.60 | $67K | +0.9% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $557.43 | $134K | +1.1% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $555.60 | $44K | +1.4% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $554.30 | $44K | +1.7% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $552.86 | $88K | +1.9% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 725 | $551.82 | $400K | +2.1% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 432 | $550.99 | $238K | +2.3% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 757 | $549.59 | $416K | +2.5% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,206 | $548.87 | $662K | +2.7% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,171 | $547.99 | $642K | +2.8% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 309 | $546.75 | $169K | +3.1% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,280 | $544.90 | $697K | +3.4% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,032 | $544.17 | $562K | +3.5% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 408 | $542.87 | $221K | +3.8% |
| Oct 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 700 | $542.06 | $379K | +4.0% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 360 | $584.66 | $210K | −3.6% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $583.28 | $233K | −3.4% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 520 | $582.24 | $303K | −3.2% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 702 | $581.21 | $408K | −3.0% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 864 | $580.20 | $501K | −2.9% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 320 | $579.02 | $185K | −2.7% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 930 | $577.93 | $537K | −2.5% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 774 | $576.91 | $447K | −2.3% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,346 | $575.90 | $775K | −2.2% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 830 | $574.94 | $477K | −2.0% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 280 | $573.62 | $161K | −1.8% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 560 | $572.86 | $321K | −1.6% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 320 | $571.52 | $183K | −1.4% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 534 | $570.55 | $305K | −1.2% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 306 | $569.65 | $174K | −1.1% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 94 | $567.90 | $53K | −0.8% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $563.31 | $90K | +0.0% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $561.68 | $45K | +0.3% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $560.05 | $67K | +0.6% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 207 | $554.70 | $115K | +1.6% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 113 | $553.78 | $63K | +1.8% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $552.63 | $66K | +2.0% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $551.50 | $88K | +2.2% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $550.47 | $220K | +2.4% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $549.40 | $132K | +2.6% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 280 | $548.25 | $154K | +2.8% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $547.29 | $219K | +3.0% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 360 | $546.23 | $197K | +3.2% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 920 | $545.13 | $502K | +3.4% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 840 | $544.05 | $457K | +3.6% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 600 | $543.25 | $326K | +3.7% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 580 | $541.76 | $314K | +4.0% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 480 | $540.78 | $260K | +4.2% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $538.65 | $22K | +4.6% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $537.67 | $108K | +4.8% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $536.52 | $86K | +5.0% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $531.11 | $85K | +6.1% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $526.09 | $42K | +7.1% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $524.62 | $42K | +7.4% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $523.36 | $42K | +7.7% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $517.16 | $41K | +9.0% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $514.90 | $41K | +9.4% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $511.37 | $20K | +10.2% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $495.32 | $20K | +13.8% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $487.79 | $39K | +15.5% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $482.36 | $77K | +16.8% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 601 | $480.79 | $289K | +17.2% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 359 | $479.67 | $172K | +17.5% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 650 | $478.47 | $311K | +17.8% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 749 | $477.43 | $358K | +18.0% |
| Sep 30 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 161 | $476.14 | $77K | +18.3% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $486.77 | $97K | +15.8% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $482.28 | $58K | +16.8% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 500 | $481.22 | $241K | +17.1% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $479.59 | $77K | +17.5% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,200 | $479.07 | $575K | +17.6% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,309 | $478.10 | $1.1M | +17.9% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,135 | $477.09 | $1M | +18.1% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,395 | $476.10 | $664K | +18.4% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 552 | $475.12 | $262K | +18.6% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $473.86 | $38K | +18.9% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 449 | $472.97 | $212K | +19.1% |
| Sep 29 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $472.05 | $189K | +19.4% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $486.00 | $78K | +15.9% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,315 | $485.45 | $638K | +16.1% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 825 | $484.47 | $400K | +16.3% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,539 | $483.20 | $744K | +16.6% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 693 | $482.11 | $334K | +16.9% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,354 | $481.20 | $652K | +17.1% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,013 | $480.18 | $486K | +17.3% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 601 | $479.06 | $288K | +17.6% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $477.45 | $95K | +18.0% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $476.68 | $76K | +18.2% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $475.28 | $38K | +18.6% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 680 | $474.46 | $323K | +18.8% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 600 | $473.28 | $284K | +19.1% |
| Sep 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 280 | $472.43 | $132K | +19.3% |
| Sep 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 632 | $478.95 | $303K | +17.7% |
| Sep 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,648 | $478.18 | $788K | +17.8% |
| Sep 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,280 | $477.19 | $611K | +18.1% |
| Sep 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,744 | $476.13 | $1.3M | +18.3% |
| Sep 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,613 | $475.28 | $767K | +18.6% |
| Sep 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 543 | $474.15 | $257K | +18.8% |
| Sep 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 800 | $472.89 | $378K | +19.2% |
| Sep 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $471.84 | $94K | +19.4% |
| Sep 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $470.56 | $19K | +19.7% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $480.33 | $19K | +17.3% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 600 | $479.52 | $288K | +17.5% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,480 | $478.61 | $708K | +17.7% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 360 | $477.58 | $172K | +18.0% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 280 | $476.51 | $133K | +18.3% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 320 | $475.35 | $152K | +18.5% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 437 | $474.01 | $207K | +18.9% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 580 | $472.73 | $274K | +19.2% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,160 | $471.77 | $1M | +19.4% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,603 | $470.63 | $1.2M | +19.7% |
| Sep 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 640 | $469.74 | $301K | +20.0% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $500.05 | $120K | +12.7% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 90 | $498.90 | $45K | +12.9% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 270 | $498.38 | $135K | +13.1% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 766 | $497.27 | $381K | +13.3% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 525 | $496.38 | $261K | +13.5% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 155 | $495.17 | $77K | +13.8% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $493.72 | $79K | +14.1% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 480 | $492.54 | $236K | +14.4% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 824 | $491.65 | $405K | +14.6% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,440 | $490.48 | $706K | +14.9% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,162 | $489.52 | $1.1M | +15.1% |
| Sep 23 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,388 | $488.70 | $1.2M | +15.3% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $499.07 | $80K | +12.9% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,358 | $497.73 | $676K | +13.2% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,484 | $496.83 | $737K | +13.4% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,488 | $495.77 | $738K | +13.7% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,337 | $494.66 | $661K | +13.9% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,645 | $493.70 | $812K | +14.1% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 628 | $492.67 | $309K | +14.4% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 736 | $491.45 | $362K | +14.7% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 424 | $490.54 | $208K | +14.9% |
| Sep 22 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $489.61 | $118K | +15.1% |
| Sep 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 843 | $496.62 | $419K | +13.5% |
| Sep 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,287 | $495.71 | $1.1M | +13.7% |
| Sep 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,170 | $494.82 | $1.1M | +13.9% |
| Sep 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,680 | $493.60 | $1.3M | +14.2% |
| Sep 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,520 | $492.97 | $749K | +14.3% |
| Sep 18 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $498.25 | $80K | +13.1% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.